ArticleNature communications2024

Delivery of a BET protein degrader via a CEACAM6-targeted antibody-drug conjugate inhibits tumour growth in pancreatic cancer models.

Youya Nakazawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.